KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) Operating Expenses: 2017-2024

Historic Operating Expenses for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to $3.0 billion.

  • BioNTech SE's Operating Expenses fell 6.96% to -$802.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 billion, marking a year-over-year increase of 1.61%. This contributed to the annual value of $3.0 billion for FY2024, which is 21.43% up from last year.
  • As of FY2024, BioNTech SE's Operating Expenses stood at $3.0 billion, which was up 21.43% from $2.5 billion recorded in FY2023.
  • In the past 5 years, BioNTech SE's Operating Expenses registered a high of $3.0 billion during FY2024, and its lowest value of $881.1 million during FY2020.
  • For the 3-year period, BioNTech SE's Operating Expenses averaged around $2.5 billion, with its median value being $2.5 billion (2023).
  • Data for BioNTech SE's Operating Expenses shows a peak YoY soared of 192.65% (in 2020) over the last 5 years.
  • Over the past 5 years, BioNTech SE's Operating Expenses (Yearly) stood at $881.1 million in 2020, then skyrocketed by 59.18% to $1.4 billion in 2021, then spiked by 46.85% to $2.1 billion in 2022, then climbed by 19.01% to $2.5 billion in 2023, then grew by 21.43% to $3.0 billion in 2024.